This Cochrane Clinical Answer evaluates long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) in people with stable COPD.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
A subscription to THE COCHRANE LIBRARY is required.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.